Socioeconomic drivers of low value screening

Abstract Low-value care brings minimal or no benefit to the patient and is a growing concern for healthcare systems. In this presentation, we will discuss the issue of low-value cancer screening, its frequency, and how it is socially patterned. The general population, policymakers, and healthcare providers expect a lot from cancer screening, while the actual absolute benefits are generally relatively low. In addition, screening practice often does not follow recommendations regarding the frequency of testing or the ages at which to start and to stop, and many screenings providing no benefit are commonly performed. Addressing low-value screening is key for evidence-based population health management and prevention.